Skip to main content
Fig. 6 | Advances in Rheumatology

Fig. 6

From: Fasciola hepatica extract suppresses fibroblast-like synoviocytes in vitro and alleviates experimental arthritis

Fig. 6

F. hepatica delayed the beginning of clinical signs of arthritis and prevented body weight loss in CIA. A Illustration of experimental design B Clinical score of arthritis during CIA development C Incidence of arthritis D Clinical score of arthritis in the hind limbs at the last day of the CIA experiment E Body weight change F Body weight change at the last day of experimentation. Data are expressed as mean ± SEM (n = 8). (B, C, E) Two-way ANOVA followed by Bonferroni post hoc test; (D, F) Student’s T-test. **p < 0.01

Back to article page